In the PIC/S PI 006-01 Guidelines, the following statements are made regarding the definition of limits.
Carry-over of product residues should meet defined criteria, for example the most stringent of the following three criteria:
a) No more than 0.1% (1/1000th) of the normal therapeutic dose of any product will appear in the maximum daily dose of the following product.
b) No more than 10 ppm of any product will appear in another product.
c) No quantity of residue should be visible on the equipment after cleaning procedures are performed.
In the last 10 years the dose-based calculation (e.g., 1/1000th dose) has prevailed in the manufacture of pharmaceutical products. Where dose data are not available, an absolute value (e.g., 10 ppm) is prescribed.
For residues where dose data are not available but toxicological data are (e.g. tensides), it is normal to perform the calculation based on the NOEL/ADI (no effect level/acceptable daily intake) value along with a safety factor (SF).
Cleaning limits are calculated on the batch level, but they also need to be calculated at the sample point level so the results for samples collected for cleaning validation and interim monitoring events after cleaning operations can be compared to these limits to confirm that the cleaning process is effective. These equations use the shared and are and the sample point area, as well as the recovery factor of the sampling method to calculate the MAC limits per sample point.